Intelligence Β· Patent portfolio
Disc Medicine Patents
Full USPTO pharma patent portfolio for Disc Medicine β grant dates, expiration, and drug cross-links.
- Patents
- 706
- Expiring β€24m
- 26
Quick answer
Disc Medicine has 706 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 26 expire within 24 months β use filters for patent-cliff planning.
-
US 7560105
Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responses
granted -
US 7541331
Surfactant treatment regimen
granted -
US 7524878
Phenyl substituted carboxylic acids
granted -
US 7498356
Substituted amino carboxylic acids
granted -
US 7482470
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
granted -
US 7465825
Phenyl substituted carboxylic acids
granted -
US 7459462
Fredericamycin derivatives
granted -
US 7452887
Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
granted -
US 7413538
Epitopes formed by non-covalent association of conjugates
granted -
US 7361671
Substituted heteroarylalkanoic acids
granted -
US 7358248
Substituted amino carboxylic acids
granted -
US 7358364
Substituted carboxylic acids
granted -
US 7332281
Therapeutic targets in cancer
granted -
US 7329680
Heterocycle substituted carboxylic acids
granted -
US 7304079
Substituted indolealkanoic acids
granted -
US 7273369
Curing light
granted -
US 7244741
Fredericamycin derivatives as medicaments for treating tumours
granted -
US 7230004
Cyclopamine analogues and methods of use thereof
granted -
US 7208602
Gamma secretase inhibitors
granted -
US 7192583
Methods for modulating bone mineralization
granted -
US 7189749
Substituted phenoxyacetic acids
granted -
US 7189385
Tooth whitening compositions
granted -
US 7183389
Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)
granted -
US 7166619
Prenylation inhibitors and methods of their synthesis and use
granted -
US 7161003
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
granted -
US 7119200
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
granted -
US 7105514
Substituted indolealkanoic acids
granted -
US 7087633
Method for treating perinatal asphyxia in a human or animal neonate
granted -
US 7086862
Tooth bleaching process
granted -
US 7084271
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
granted -
US 7084154
2-(aminomethyl) arylamide analgesics
granted -
US 7078525
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
granted -
US 7074924
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
granted -
US 7067661
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
granted -
US 7060256
Increased peroxide content tooth bleaching gel
granted -
US 7037916
Pyrimidine derivatives as IL-8 receptor antagonists
expired -
US 7034056
Aryl and biaryl compounds having MCH modulatory activity
expired -
US 6986883
Increased peroxide content tooth bleaching gel
expired -
US 6986891
Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof
expired -
US 6964980
Method of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substitute indolealkanoic acids
expired -
US 6943161
Pyrimidine and triazine kinase inhibitors
expired -
US 6933306
Hydroxamic and carboxylic acid derivatives
expired -
US 6919347
Bradykinin B1 receptor antagonists
expired -
US 6903131
3,4-di-substituted maleimide compounds as CXC chemokine receptor antagonists
expired -
US 6900213
Bisaryl derivatives having FSH modulatory activity
expired -
US 6894069
Method for treating perinatal asphyxia in a human or animal neonate
expired -
US 6887865
N-heterocyclic derivatives as NOS inhibitors
expired -
US 6887889
Aryl and biaryl piperdines with MCH modulatory activity
expired
Frequently asked questions
How many patents does Disc Medicine have?
706 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Disc Medicine patents expire?
26 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory